Add Yahoo as a preferred source to see more of our stories on Google. A man whose hands were left unusable by a rare disease has been given a new lease of life after what is believed to be the world's ...

Pivotal trial to support marketing approval of regenerative cells processed with the Celution® System to commence in Q2 2022 SAN DIEGO--(BUSINESS WIRE)--Paracrine, Inc. announced today that the FDA ...

A man in Scotland whose hands were left unusable by scleroderma has been given a new lease of life after what is believed to be the world’s first double hand transplant for the condition. Steven ...

SAN DIEGO--(BUSINESS WIRE)--Paracrine, Inc., announced today the online publication (ahead of print) of the findings from the STAR I trial in Arthritis & Rheumatology Journal, the official journal of ...

A dad who lost the use of his hands to a rare disease has had them replaced in a world-first operation. Steven Gallagher, 48, suffered scleroderma, a condition where the skin hardens and tightens. He ...

Suggested Citation: "4 Scleroderma." National Academies of Sciences, Engineering, and Medicine. 2022. Selected Immune Disorders and Disability. Washington, DC: The National Academies Press. doi: ...

Epigenetic drugs that have shown promise in cancer trials significantly reduce scarring in the cells of patients with scleroderma, a new study shows. Results reveal that drugs that inhibit BRD4, known ...

Two new studies led by researchers at Hospital for Special Surgery (HSS) have uncovered key biological mechanisms driving systemic sclerosis (SSc), or scleroderma – a rare and often devastating ...